Mepitel薄膜预防乳腺癌放射性皮炎的可行性研究
结果显示无患者发生3级及以上RD,5例(17.9%)发生2级RD,其中3例(10.7%)出现湿性脱屑。结论认为Mepitel薄膜完全预防了3级RD,但未实现既往试验中湿性脱屑的完全预防。
要点
- 湿性脱屑3例(10.7%),未达既往试验的完全预防效果。
- 2例(6.7%)在放疗完成前停用Mepitel薄膜,可行性可接受。
核心结论
- Mepitel薄膜在加拿大中心可行,并完全预防了3级RD,但未完全预防湿性脱屑。
主要发现
- 无患者发生3级及以上RD;5例(17.9%)发生2级RD,其中3例(10.7%)湿性脱屑、2例(7.1%)为无湿性脱屑的明显红斑。
- 2例(6.7%)在放疗完成前停用Mepitel薄膜。
关键数值与推荐
- 主要结局为按CTCAE分级的RD;次要结局包括湿性脱屑、患者和临床医生报告的皮肤毒性症状及美容结局。
临床怎么用
- Mepitel薄膜可作为乳腺癌放疗患者预防严重RD的可选措施,但需注意湿性脱屑仍可能发生。
局限性
- 单中心小样本可行性研究,未与标准预防措施头对头比较,需进一步研究确认疗效并识别最受益人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Severe radiation dermatitis (RD) is distressing and may have adverse long-term effects including fibrosis and telangiectasia. Treatment interruptions due to severe RD may increase the risk of recurrence. Two randomized trials of Mepitel film demonstrated efficacy in preventing severe RD in breast cancer, but this product has not been widely adopted in North America. We aimed to assess the feasibility and efficacy of Mepitel film for prevention of breast RD at a Canadian center. METHODS AND MATERIALS: Patients were stratified based on breast size and receipt of postmastectomy radiation therapy. The primary outcome was RD grade using the Common Terminology Criteria for Adverse Events. Secondary outcomes included moist desquamation, patient- and clinician-reported symptoms of skin toxicity, and cosmetic outcomes. RESULTS: Thirty patients receiving external beam radiation therapy to the breast or chest wall were enrolled. Two patients (6.7%) discontinued use of the Mepitel film before completing radiation therapy. No patients developed grade 3 RD or higher. Five patients (17.9%) developed grade 2 RD: 3 (10.7%) had moist desquamation, and 2 (7.1%) had brisk erythema without moist desquamation. CONCLUSIONS: Mepitel film completely prevented grade 3 RD. Rates of moist desquamation and grade 2 RD were lower with Mepitel film than in studies using aqueous cream, but unlike previous trials of Mepitel film we did not achieve complete prevention of moist desquamation. Further research is needed to confirm the efficacy of Mepitel film versus standard prophylaxis for RD and identify the patients who will benefit the most from the film.
引用
- Yee C, Lam E, Gallant F, et al. A Feasibility Study of Mepitel Film for the Prevention of Breast Radiation Dermatitis in a Canadian Center. Pract Radiat Oncol. 2020. PMID: 32949772. doi:10.1016/j.prro.2020.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。